Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Equity Average (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Equity Average for 15 consecutive years, with $33.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average rose 28.11% year-over-year to $33.7 million, compared with a TTM value of $33.7 million through Sep 2025, up 28.11%, and an annual FY2024 reading of $26.9 million, up 52.21% over the prior year.
  • Equity Average was $33.7 million for Q3 2025 at Rockwell Medical, up from $31.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $33.7 million in Q3 2025 and bottomed at -$1.1 million in Q1 2022.
  • Average Equity Average over 5 years is $19.6 million, with a median of $21.0 million recorded in 2024.
  • The sharpest move saw Equity Average plummeted 103.76% in 2022, then skyrocketed 1272.89% in 2023.
  • Year by year, Equity Average stood at $6.8 million in 2021, then skyrocketed by 121.89% to $15.1 million in 2022, then soared by 41.55% to $21.4 million in 2023, then surged by 44.18% to $30.9 million in 2024, then grew by 9.25% to $33.7 million in 2025.
  • Business Quant data shows Equity Average for RMTI at $33.7 million in Q3 2025, $31.0 million in Q2 2025, and $32.1 million in Q1 2025.